Core Viewpoint - Dongxin Co., Ltd. has shown a significant stock price increase of 42.57% year-to-date, but faces serious operational challenges with consecutive net losses projected for 2023 and 2024, raising concerns about its financial health [1][3]. Financial Performance - The company reported a net profit decline starting in 2022, with a projected loss of 0.59 billion yuan in Q1 2025 [1]. - As of July 22, 2023, the company's A-share market capitalization stood at 15.7 billion yuan [1]. Inventory Issues - Dongxin's inventory balance reached 1.121 billion yuan at the end of 2024, accounting for 161.87% of operating costs and 34.16% of current assets [3]. - The company reported a decrease in inventory impairment provision by 33% year-on-year, raising concerns about the adequacy of provisions given the high inventory levels [3]. Gross Margin Fluctuations - The overall gross margin for 2024 was 13.99%, an increase of 2.42 percentage points year-on-year, but product-specific margins varied significantly [6]. - NAND and NOR product margins increased by 8.25 and 6.89 percentage points respectively, while DRAM margins decreased by 7.01 percentage points [6]. Accounts Receivable Concerns - Accounts receivable surged to 159 million yuan at the end of 2024, a year-on-year increase of 67.86%, significantly outpacing revenue growth of 20.8% [6]. - The company reported a 121.59% increase in accounts receivable from direct sales customers, with only a slight increase in bad debt provisions, raising questions about credit policies [6]. Transparency of Overseas Assets - The company has overseas assets valued at 552 million yuan, constituting 15.64% of total assets, but lacks detailed disclosure on their distribution and usage [7]. - There are discrepancies noted by auditors regarding export revenue and VAT declarations, indicating potential risks in revenue recognition [7].